Manipal Health Enterprises Limited
RHP · filed 24 Jul 2026
Manipal Health Enterprises is a healthcare provider that generates revenue primarily from inpatient care across specialty departments such as cardiac sciences and oncology. The offer consists of a fresh issue of 8000 crore rupees with no offer for sale portion. The company's financial trajectory is supported by pro forma information illustrating the impact of recent acquisition transactions. Material risks include high geographic concentration in Karnataka, reliance on specific medical specialties, and the potential for inconsistent patient volumes or occupancy rates.
Partial analysis — some sections could not be read from the document (found: capitalisation, litigation, objects, price_basis, promoters, related_party, risks).
What stands out
Risk factor. A substantial number of our hospitals are located in Karnataka. We derived 46.40%, 51.55%, and 59.98% of our revenue from operations in Fiscals 2026, 2025 and 2024, respectively, from our hospitals in Karnataka. Any loss of business or disruption in the operations of these hospitals or geopolitical
Risk factor. We primarily generate revenue by providing inpatient care at our hospitals. Any inability to maintain or improve our admissions and hospital occupancy rates could adversely affect our business, financial condition, results of operations, cash flows and prospects. We are susceptible to risks of incon
Risk factor. We derived 64.30%, 62.56% and 61.55% of our gross inpatient revenue from cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences (CONGO-R) specialties in Fiscals 2026, 2025 and 2024, respectively. Any negative changes in the demand for these specialties could adv
Primarily fresh capital. 100% of the offer is fresh issue, so most proceeds fund the company.
How the offer is structured
Fresh issue
₹8.00k Cr
New capital into the company
OFS share
0%
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of our Material Subsidiaries, namely, Manipal Hospitals Private Limited₹5.55k Cr
- Acquisition of minority stake in our stepdown Subsidiary, Sahyadri Hospitals Private Limited₹574 Cr
- General corporate purposes
Promoters, litigation & related parties
Promoter (pre)
69.9%
Related-party
0.4%
Share of revenue
Except as disclosed in this section
Risks the company discloses
A substantial number of our hospitals are located in Karnataka. We derived 46.40%, 51.55%, and 59.98% of our revenue from operations in Fiscals 2026, 2025 and 2024, respectively, from our hospitals in Karnataka. Any loss of business or disruption in the operations of these hospitals or geopolitical or policy changes in Karnataka could have a material adverse effect on our business, financial condition, results of operations, cash flows and prospects.(Geographic Concentration)
We primarily generate revenue by providing inpatient care at our hospitals. Any inability to maintain or improve our admissions and hospital occupancy rates could adversely affect our business, financial condition, results of operations, cash flows and prospects. We are susceptible to risks of inconsistent or declining patient volumes and/or hospital occupancy levels.(Operational Performance)
We derived 64.30%, 62.56% and 61.55% of our gross inpatient revenue from cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences (CONGO-R) specialties in Fiscals 2026, 2025 and 2024, respectively. Any negative changes in the demand for these specialties could adversely impact our business, results of operations and financial condition.(Revenue Concentration)
The ramp-up of new or expanded facilities may entail longer than expected lead times before achieving the targeted occupancy rates. Any failure by us to maintain or improve our admissions or occupancy rates may result in reduced profit margins, which may have an adverse impact on our business, financial condition, results of operations, cash flows and prospects.(Operational Performance)
Any significant slowdown in economic activities, social, political or economic disruption, sustained economic downturn or natural calamities or civil disruptions in Karnataka, or any changes in the policies of the state or local governments of this region or the Government of India, could disrupt our business operations, reduce the demand for our services, hamper the supply of medical supplies, require us to incur significant expenditure or change our business strategies.(Geographic Concentration)
Patient volumes and occupancy rates at our hospitals, and our ability to improve them, are affected by many factors within our control, such as our ability to attract and retain healthcare professionals, our ability to maintain and expand our specialty offerings and advanced equipment, our ability to price our offerings affordably, and our brand recognition, as well as by factors beyond our control, such as febrile illness cycles, climate and weather conditions, patient demand and competition.(Operational Performance)
Any negative changes in the demand for these specialties, due to unavailability of preferred doctors, shifts in patient preferences, advancements in alternative treatments, increased competition or otherwise, could adversely impact our business, results of operations and financial condition. Additionally, our reliance on these specialties may limit our ability to adapt to changing market conditions or diversify our service offerings.(Revenue Concentration)
We have also presented pro forma financial information as of March 31, 2025 and for Fiscal 2025 and Fiscal 2026 in this Red Herring Prospectus, which is based on the Pro Forma Financial Information, to illustrate the impact of the Acquisition Transactions undertaken as if the acquisitions had taken place. Our Pro Forma Financial Information may not be indicative of our actual results of operations and financial position for such periods or as of such dates, or of expected results of operations in future periods or our future financial position.(Financial Reporting)